TriLink BioTechnologies, part of Maravai LifeSciences

Christopher Greely’s journey from California State University San Marcos to TriLink BioTechnologies, part of Maravai LifeSciences shows how a passion for science can shape a rewarding career! As a proud alum, his story was recently featured in CSUSM News, highlighting how his education and drive paved the way for his impact in the industry. ? Read about his journey here: https://lnkd.in/dzd2GdwV ? #CareerJourney #AlumSpotlight #Biotech #EmployeeSpotlight

Maravai LifeSciences is excited to announce today that it has completed its previously announced acquisition of?Officinae Bio’s DNA and RNA business.?This?acquisition?combines Officinae Bio's AI-enabled mRNA design platforms with Maravai and?TriLink BioTechnologies, part of Maravai LifeSciences'?leading drug substance manufacturing capabilities, providing customers comprehensive expertise and novel technologies for quick, calculated progression through the mRNA sequence-optimization phase and into clinical testing and commercial manufacturing. https://lnkd.in/eYpRUjKF #RNA #DNA #acquisition

?? What’s next for?RNA therapeutics in 2025? Kate Broderick, Chief Innovation Officer at Maravai LifeSciences, shares her key 2025 predictions for RNA therapeutics in The Medicine Maker.?From cutting-edge innovations to real-world impact, the future of RNA is brighter than ever. ? Read the full article here: https://lnkd.in/gK966GWV ? #RNA #2025 #Biotech #HealthcareInnovation #RNATherapeutics

A clinically approved therapeutic for pre-eclampsia is one step closer with the development of ionizable LNPs that target the placenta for mRNA delivery. Learn how TriLink’s CleanCap? Reagent AG and N1-Methylpseudouridine-5'-Triphosphate facilitated this discovery in our latest research spotlight. #mRNA #pregnancy #research

????Happy Valentines Day from us here at TriLink BioTechnologies, part of Maravai LifeSciences, where we'll always choose U(racil)!? ? #ValentinesDay #RNA #Uracil #Biotech

????Celebrating 10 years of the International Day of Women and Girls in Science! We are incredibly grateful for the brilliant women at TriLink BioTechnologies, part of Maravai LifeSciences who lead, innovate, and inspire every day.? ? Let's continue to break barriers, challenge stereotypes, and empower the next generation of women in STEM.? ? ?#IDWGS #WomenInScience #WomenInSTEM #Biotech

This blog discusses the evidence for protein folding as a driver for evolutionary change in trait correlations of single proteins. For their investigation, Dasmeh et al. employed E. coli bacteria genetically engineered to express random variants of yellow fluorescent protein (YFP) as a model system. The required DNA variants of the YFP gene were produced by error-prone PCR (epPCR) using TriLink BioTechnologies, part of Maravai LifeSciences 8-oxo-2'-deoxyguanosine-5'-triphosphate (8-oxo-dGTP) and 2'-deoxy-P-nucleoside-5'-triphosphate (dPTP).?? #research #DNA #proteins Andreas Wagner

We are excited to announce that we have entered a license and supply agreement for our CleanCap? mRNA capping technology with Aldevron! TriLink BioTechnologies, part of Maravai LifeSciences will supply our CleanCap? cap analogs for use in Aldevron's mRNA development and manufacturing services, from pre-clinical through Phase III programs. This partnership sets the stage for advancing critical therapeutics, and we're eager to provide our solutions to Aldevron and its customers! ? Read more at: https://lnkd.in/dM_cR6wK ? #PressRelease #LifeSciences #CleanCap #mRNA?

We’re thrilled to announce our new partnership with VWR, part of Avantor! This collaboration will expand availability of our cutting-edge nucleic acid technologies across Europe, leading to advancements in ordering processes and offering shorter lead times. We can't wait to better serve the region's growing demand for innovative solutions and support the advancement of life-changing therapeutic research, thanks to this partnership. ? Read more at: https://lnkd.in/gaADu343 ? #mRNA #pressrelease #partnership #LifeSciences

Don’t let dsRNA derail your research. Join us to uncover the power of an RNA polymerase designed for efficient and cleaner mRNA synthesis. Your next breakthrough starts here! Watch our webinar that discusses a novel RNA Polymerase that reduces dsRNA by up to 85%. https://lnkd.in/gWj9F9NS #webinar #RNA #breakthrough